5 • 716 Ratings
🗓️ 17 February 2022
⏱️ 11 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | Hey all, welcome back to the Real Life Pharmacology podcast. I'm your host, pharmacist, Derek Christensen, |
0:05.5 | and I thank you for listening today. As always, go check out Real Life Pharmacology.com. |
0:11.5 | Grab your free 31-page PDF on the top 200 drugs. Great study guide, great review if you're going |
0:18.4 | through pharmacology classes right now, or just a great refresher if you're going through pharmacology classes right now or just a great |
0:22.8 | refresher if you're out in practice. So again, real-life pharmacology.com. Snaug that free |
0:28.6 | PDF on the top 200 drugs. All right, let's get into the drug of the day today, and that is |
0:34.4 | Pravastatin. Brand name of this medication is Pravacol. |
0:39.2 | I have seen use kind of slowly decline over time. |
0:45.1 | Occasionally I get a patient on this medication. |
0:49.8 | It is a cholesterol agent, or an anticholesterol agent, I guess, and classified as a statin as well. |
0:58.2 | So it ultimately lowers cholesterol, lowers LDL, which is usually what we're targeting to treat. |
1:05.3 | It can help with reduction of MI and stroke, and that's really primarily what it's going to be used for. |
1:12.7 | Mechanistically, it's a statin, so it's going to inhibit HMG COA reductase. If you recall, this is |
1:21.5 | the rate limiting step in the body's production of cholesterol. |
1:32.9 | And again, specifically, that's going to ultimately help lower LDL. |
1:43.0 | Now, one of the big downsides of pravastatin and why its use has, I think, slowly decreased over time is that you can only get to moderate intensity |
1:47.7 | lowering effects. And so what do I mean by that? So if you remember there's mild, |
1:54.1 | moderate, and high intensity statins, or low intensity, moderate intensity and high |
2:00.2 | intensity statins. And and high intensity statins. |
2:01.9 | And the high intensity statins, atorvastatin, and rosuvastatin, which I've covered in |
2:08.3 | podcasts before, those are typically the go-to agents because a lot of times in patients that |
2:15.2 | need cholesterol lowering therapy, we're thinking they might need |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.